TotalMarketCap

Nautilus Biotechnology

NAUTNasdaq United StatesIndustrialsBiotechnology: Laboratory Analytical Instruments

Market cap

$277.035 M

$2.18 -5.02%

Close of 6 Nov 2026

As of 6 Nov 2026, Nautilus Biotechnology (NAUT) has a market capitalization of $277.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$59.0M

Loss-making

Shares outstanding

127,372,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →
  1. #10Pacific Biosciences Of CaliforniaPACB$756.9M
  2. #11Cytek BiosciencesCTKB$704.3M
  3. #12Nautilus BiotechnologyNAUT$277.0M
  4. #13Standard BiotoolsLAB$245.3M
  5. #14QuanterixQTRX$130.1M

What if Nautilus Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$221,687.50

Per share 101,925× higher

Bitcoin $1.53T

$11,995.12

Per share 5,515× higher

Apple $5.02T

$39,378.87

Per share 18,105× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Nautilus Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.